Social media has become one of the main ways clinics, doctors and healthcare groups in Dubai communicate with existing and prospective patients.
Instagram reels explain procedures. Doctors build professional profiles on LinkedIn and Instagram. Clinics promote packages and services through paid campaigns. Patient stories, videos and educational content are increasingly part of everyday healthcare marketing.
But healthcare advertising is not the same as ordinary consumer advertising, and DHA social media advertising rules exist precisely because of that difference.
Dubai Health Authority’s Health Regulation Sector has issued Standards for Medical Advertisement Content on Social Media, which apply to every DHA-licensed healthcare facility and healthcare professional in Dubai’s private healthcare sector. The standard reflects the growing promotion of healthcare services through social media and the importance of credible, ethical medical advertising, and it remains a live compliance requirement for every clinic active on social platforms today.
For clinic owners, Medical Directors, healthcare professionals and marketing teams, the practical question is therefore not simply, “Is our social media performing?” It is also, “Is the content we are publishing appropriate, supportable and properly governed?”
Important: This article provides general business and operational information and does not constitute legal or regulatory advice. Healthcare organisations should review the current DHA requirements and obtain appropriate professional guidance where necessary.
Social media advertising includes more than paid advertisements
A common mistake is to think healthcare advertising rules matter only when a clinic pays Meta, Google or another platform to promote a campaign.
DHA defines a Social Media Advertisement broadly as information concerning a health product, service, facility, professional, treatment or therapy communicated through social media. The standards refer to platforms including Instagram, Facebook, LinkedIn, YouTube, WhatsApp and other social-networking and content-sharing platforms.
That means healthcare organisations should think beyond sponsored campaigns. A doctor’s Instagram reel, a clinic’s LinkedIn post, a treatment video, or how a clinic uses social platforms to promote packages and services may all require the same level of governance as a formal advertising campaign.
1. Make sure professional titles match the licence
Marketing language often becomes more creative as competition increases. That can create problems in regulated healthcare.
The DHA standard states that healthcare professionals and staff should not use names or specialty titles that differ from their DHA licence. It also addresses appropriate use of the title or prefix “Doctor”. Marketing teams should not independently rewrite professional titles because they sound more attractive online.
- Check the professional’s licensed title and specialty.
- Verify qualifications referenced in captions and graphics.
- Keep website, social accounts and regulatory records consistent.
- Escalate any uncertainty before publication.
2. Treatment claims need to be supportable
Healthcare marketing naturally tries to communicate benefits, but language that works in another industry can be inappropriate in healthcare. DHA requires medical social-media advertising to be substantiated, particularly when referring to treatment outcomes, and emphasises reliable and factually accurate information.
Expressions suggesting guaranteed success, immediate results, no side effects or absolute certainty require particular caution.
A practical test
Before publishing a claim, ask: Could we objectively support this statement if a regulator, patient or professional colleague asked us to demonstrate the evidence behind it?
If the answer is no, reconsider the wording. Marketing should explain value without creating unrealistic expectations.
3. The Medical Director has an important governance role
Healthcare social media should not sit completely outside the organisation’s clinical governance structure. DHA’s standards assign responsibilities to the Medical Director and state that Medical Directors are accountable for the content and style of social media advertisements on accounts promoting the healthcare facility.
In some organisations, ownership is unclear: an agency prepares the content, a social-media executive schedules it, a physician appears in it and management approves the budget, but nobody owns the final clinical and regulatory review. That is the gap clinic leaders need to close.
A practical healthcare content approval process
Content Creation → Marketing Review → Clinical Review → Compliance Check → Approval → Publish → Archive → Monitor
Not every routine post needs an unnecessarily complex approval committee. The objective is proportional governance. A simple opening-hours announcement may require little review, while content discussing treatment outcomes, patient images or promotional packages should receive much closer scrutiny.
4. Separate professional and personal social-media activity
Doctors increasingly build their own professional brands. That can benefit the clinician and the facility, but it also creates governance challenges.
The DHA standards say healthcare professionals should maintain separate personal and professional accounts and clearly state professional information, including their name, title, qualification and specialty, consistently with their DHA licence.
- Clarify which account represents the facility and which represents an individual professional.
- Define who controls account credentials and what happens when a professional leaves.
- Identify which content requires facility approval.
- Document how inaccurate or inappropriate content will be corrected.
5. Patient images and videos need careful control
Patient stories can be powerful. They can also create significant privacy, ethical and regulatory risk. The DHA standard requires written and documented consent where a patient’s pictures, images, videos or statements are used in social-media advertisements.
A verbal “the patient said it was fine” is not a strong governance process. A clinic should document the intended use, platforms, consent record, publication approval, identifiability, storage and future-use or withdrawal considerations. Marketing content should never be treated as an exception to patient privacy controls.
6. Be particularly careful with before-and-after content
Before-and-after imagery is widely used in aesthetics, dermatology, dentistry and cosmetic healthcare. DHA’s standards specifically address this content, including the need for appropriate disclaimers and for images not to be misleading.
Clinics should check that images are comparable, authentic and supported by documented consent; that lighting, angle and editing do not create a false impression; and that the content does not imply the same result is guaranteed for every patient.
7. Promotions should not create pressure or fear
Healthcare offers and packages often use urgency, scarcity and emotional language. In a clinical setting, those techniques need careful handling. Patients should not be pressured into healthcare decisions through exaggerated fear, misleading urgency or claims that exploit vulnerability.
Review the full message, not just the headline. Price, eligibility, exclusions, expiry, clinical suitability and material limitations should be communicated accurately. Healthcare marketing should help patients make informed decisions; it should not manufacture anxiety.
8. Influencers do not sit outside healthcare advertising governance
Doctors themselves can become influencers, while clinics increasingly collaborate with creators and public personalities. That does not eliminate the healthcare organisation’s responsibility for the message.
- Review the claim being made and how the treatment is represented.
- Check whether the content creates unrealistic expectations.
- Address patient privacy, disclosures and required approvals.
- Retain the final published material and approval evidence.
The regulatory consequence should not be ignored
This is not just a brand-management exercise. Dubai’s regulatory framework identifies publishing a health promotion without the relevant DHA authorisation as a violation and separately addresses failure to comply with DHA requirements concerning health promotion.
Executive Council Resolution No. 49 of 2024, which governs the practice of health professions and health activities in Dubai, sets out financial penalties sized to the severity of the breach: for a health professional, fines can range from AED 2,000 up to AED 100,000; for a healthcare facility, fines can range from AED 5,000 up to AED 200,000. Advertising or promoting healthcare services without the required DHA authorisation falls within this framework, alongside broader regulatory consequences that may apply depending on the underlying violation.
The objective should not be to make marketing slower. It should be to make the approval process clearer and safer.
A 10-point healthcare social-media review checklist
- Does the advertised service fall within the facility’s authorised scope?
- Are professional names and titles consistent with DHA licensing?
- Can every clinical or outcome-related claim be substantiated?
- Does the wording avoid guarantees or unrealistic expectations?
- Are risks or limitations appropriately represented where relevant?
- Has patient consent been formally documented for patient-related content?
- Have before-and-after images been handled appropriately?
- Has the relevant clinical or Medical Director review taken place?
- Have regulatory advertising approvals been considered where required?
- Can the clinic demonstrate who approved the content and retain a record afterward?
If several answers are unclear, the organisation does not necessarily have a marketing problem. More often, it points to a governance problem.
FREE PRACTICAL RESOURCE
Healthcare Social Media Compliance Review Kit, Dubai 2026
A practical seven-page checklist, risk matrix, approval workflow, approval record, patient-content review and self-assessment tool for clinics and healthcare groups.
We will email you the kit and may follow up about your compliance review.
The bigger issue for clinic groups: marketing governance
As clinics grow, marketing activity often becomes distributed. Individual doctors post independently. Agencies manage paid campaigns. Branch managers create local promotions. Influencers publish collaborations. The corporate marketing team runs its own calendar.
Without an agreed governance model, nobody has a complete view of what is being communicated under the organisation’s name. A stronger framework defines who creates, who clinically reviews, who checks compliance, who approves, who publishes, who monitors and who keeps the evidence.
For organisations planning expansion or new services, governance should be designed alongside the wider clinic-opening and licensing process, not added after campaigns have already started.
How OzaniX can support healthcare organisations
OzaniX Partners works across healthcare Digital Growth, Licensing & Regulatory support and operational governance. For clinics and healthcare groups, this can include reviewing the operating process behind healthcare marketing, defining responsibilities, strengthening content-approval workflows and coordinating regulatory readiness alongside digital-growth workstreams.
Concerned about your current healthcare marketing process?
Request an initial Healthcare Marketing & Compliance Review. We can review your current workflow, identify obvious governance gaps and help determine where stronger controls may be required.
Sources and regulatory references
- Dubai Health Authority, Standards for Medical Advertisement Content on Social Media (DHA/HRS/HPSD/ST-21, Version 1.1).
- Executive Council Resolution No. 49 of 2024 regulating health professions and health activities in Dubai.
Healthcare organisations should always confirm the latest applicable requirements with the appropriate authority before acting.
